Most clinical trial recruitment doesn’t fail because of bad science. It fails because sponsors keep running the same recruitment playbook and expecting a different result.
Roughly 80% of trials miss their enrollment deadlines — not by days, but by months. Every day of delay can cost sponsors anywhere from $37K to $8M.
Recruitment isn’t one problem — it’s a chain of them, and patients fall off at every link for reasons that are almost always fixable. Here are the 10 biggest breakdowns, and what actually works to fix them.
1. Most patients don't even know a trial exists.
Only 16% of patients say a doctor has ever mentioned a trial to them. On top of that, there’s a widespread myth that trials are only a “last resort” — so a lot of people don’t even realize trials are an option, don’t know what they’d involve, and have no idea they might qualify.
The Fix: Broader patient education, delivered where patients already are. Talk to them in plain language, not medical jargon, so they understand what trials actually are, what their options look like, and why participating might be worth it in the first place.
2. It's too far to travel.
Most people won’t drive more than 30 miles for a trial — and for anyone rural, working full-time, caring for kids, or already managing a chronic illness, that distance alone can be a dealbreaker, no matter how good the trial is.
The Fix: Target patients realistically near trial sites, and shrink the actual distance with things like video visits, local labs, and at-home nursing — so a 3-hour round trip doesn’t stand between someone and a treatment that could help them.
3. It's hard to even find the right patients
Medical records live in a dozen different systems that don’t talk to each other, and the codes doctors use are too vague to capture what a trial actually needs — like specific lab thresholds. Ask patients to self-report that detail, and you’re relying on people to understand and translate their own medical jargon, which most people can’t do accurately.
The Fix: Combine multiple data sources with simple, plain-language screening questions that don’t assume patients know medical terminology — so eligible people aren’t missed just because of how the question was phrased.
4. The trial's own rules are too strict.
Up to half of interested patients get screened out before they even start — often not because they’re genuinely a bad fit, but because the eligibility rules were copied from an old study and never revisited to see if they still make sense.
The Fix: Test the trial’s requirements against real patients before launch, and loosen or rewrite rules that are excluding people for no good scientific reason.
5. Patients don't trust the process.
For many communities — especially Black, Hispanic, and Indigenous patients — distrust of clinical research isn’t paranoia. It comes from a real, documented history of harm. Generic, corporate-sounding outreach doesn’t fix that; it just confirms the distance patients already feel.
The Fix: Use messengers those communities already trust, real patient stories instead of stock messaging, and be upfront about what participation actually involves before ever asking someone to take a next step.
6. You're losing interested patients to your own process.
Someone sees an ad, fills out a form, maybe even books a call — genuinely interested, ready to go. Then a slow callback, a confusing next step, or one too many forms to fill out is all it takes to lose them. It’s not that they stopped caring. It’s that the process gave them too many chances to give up.
The Fix: Respond to interested patients within 24 hours, follow up consistently instead of just once, and cut out every extra step between “I’m interested” and “I’m enrolled.”
7. Trial sites are overwhelmed.
Even a flawless recruitment campaign is wasted if the doctor’s office receiving those leads is drowning. Coordinators are often juggling multiple trials at once with lean staff, so referrals can sit untouched for days or weeks before anyone even follows up.
The Fix: Check that a site can actually handle new patients before sending them any, connect systems directly so referrals don’t get lost in email, and handle more of the screening work before it ever reaches an overloaded coordinator.
8. Sponsors are tracking the wrong numbers.
Ad clicks and cheap leads look great on a report — but they don’t actually tell you if people are enrolling. When teams get rewarded for volume instead of quality, you end up with a flood of leads that don’t convert, and nobody notices until the trial’s already behind.
The Fix: Track how many patients actually make it through each step, not just how many people clicked an ad, and use real-time dashboards to catch problems in weeks instead of months.
9. Trial participants still don't look like real patients.
Trial groups keep skewing toward people who live near major academic hospitals — which usually means they don’t reflect the actual population the treatment is meant to help. Diversity too often gets treated as a box to check at the end, instead of something built in from the start.
The Fix: Recruit through community health centers and organizations people already trust in their own neighborhoods, and set real diversity goals when the trial is first being designed — not scrambled for once enrollment is already behind.
10. The timeline was unrealistic from the start.
Plans get built assuming everything goes perfectly — fast approvals, top-performing sites, patients lining up on day one. When reality doesn’t cooperate, sites start rushing people through just to hit a number, and that’s when data quality suffers.
The Fix: Build timelines around what actually tends to happen, not best-case guesses, plan for setbacks in advance, and make sure one team owns the whole process from start to finish instead of everyone managing their own piece.
It's not a patient shortage, it's an insight shortage
Almost none of these challenges are really about a shortage of patients. They’re about a shortage of patient awareness, patient consideration, and trials built around what’s actually feasible for the people who’d be participating in them.
Patients are already online, in communities and forums, comparing notes and looking for exactly the kind of information a trial could offer them. The real fix isn’t a bigger ad spend or a longer site list — it’s listening to what patients are actually saying, and building trials around what they can realistically do, instead of what you assume they should do.
Get that patient insight at the start, and you’re not chasing patients until the last day of enrollment.